R&D | January 14, 2026
Zealand Pharma taps Denmark’s supercomputer to supercharge drug discovery
Gefion, powered entirely by renewable energy, boasts more than 1,500 NVIDIA GPUs
Gefion, powered entirely by renewable energy, boasts more than 1,500 NVIDIA GPUs
SandboxAQ will receive an upfront payment and could earn up to $200 million in milestone payments tied to preclinical, development, regulatory, and commercial achievements
Expands bioprocessing footprint across Asia
The platform integrates with CT imaging and uses deep learning models to generate a 3D digital twin of lung anatomy
Expanded capabilities that continue to push the boundaries of innovation—advancing drug delivery solutions for patients, customers, and consumers around the world
Protein L is known as a “superantigen” because it can bind antibodies in unusual ways
The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
The collaboration aims to enhance the accuracy of physics-based methods with AI models for optimising small molecule medicine discovery and development
The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development
This two-day program was attended by 40 doctors & paramedical staff
Subscribe To Our Newsletter & Stay Updated
